scispace - formally typeset
G

Geoffrey N. Smith

Researcher at University of British Columbia

Publications -  64
Citations -  2126

Geoffrey N. Smith is an academic researcher from University of British Columbia. The author has contributed to research in topics: Psychosis & Schizophrenia. The author has an hindex of 25, co-authored 64 publications receiving 1962 citations. Previous affiliations of Geoffrey N. Smith include Riverview Hospital & St. Vincent's Health System.

Papers
More filters
Journal ArticleDOI

Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins

TL;DR: In healthy subjects, myelin water fraction in total white matter and in frontal white matter increased with age, and with years of education, indicating ongoing maturation, and in patients with schizophrenia, neither relation was statistically significant.
Journal ArticleDOI

An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone.

TL;DR: This group of first-episode patients did not exhibit abnormalities of basalganglia volumes, nor were basal ganglia volumes affected by exposure to risperidone, suggesting effects of both illness and medications.
Journal ArticleDOI

Ventricular and sulcal size at the onset of psychosis.

TL;DR: To determine whether abnormalities in brain morphology are present at the onset of illness, patients with schizophrenia, schizophreniform and bipolar disorders, and major depression who were experiencing their first episodes of psychosis were compared with normal and medical control subjects.
Journal ArticleDOI

The hotel study: multimorbidity in a community sample living in marginal housing.

TL;DR: This marginally housed cohort had greater than expected mortality and high levels of multimorbidity with adverse associations with role function and likelihood of treatment for psychosis, which may guide the development of effective health care delivery in the setting of marginal housing.
Journal ArticleDOI

Reduced Basal Ganglia Volumes After Switching to Olanzapine in Chronically Treated Patients With Schizophrenia

TL;DR: Olanzapine reversed putamen and globus pallidus enlargement induced by typical antipsychotics but did not alter volumes in patients previously treated with risperidone.